RSLSUnknown
ReShape Lifesciences Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for ReShape Lifesciences Inc. (RSLS), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are RSLS insiders buying or selling?
ReShape Lifesciences Inc. insiders reported no open-market purchases or sales in the last 12 months. Since January 2019, Trabud has recorded 30 Form 4 filings for RSLS: 29 buys ($495.5K) and 1 sells (-$2.8K).
Source: SEC EDGAR Form 4
Key Statistics (January 2019 – Dec 4, 2020)
Total Form 4 filings
30
SEC EDGAR
Insider filers
3
Insider buys (29)
$495.5K
Insider sells (1)
-$2.8K
Insider sentiment
Net buyingNet insider flow of $498.3K in net buying since January 2019.
Recent RSLS insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Dec 4, 2020 | Steven Boyd | 10% Owner | Purchase | 6.4K | $4.16 | $26.6K | SEC ↗ |
| Nov 18, 2020 | Steven Boyd | 10% Owner | Purchase | 977 | $4.21 | $4.1K | SEC ↗ |
| Nov 12, 2020 | Steven Boyd | 10% Owner | Purchase | 2.4K | $3.58 | $8.6K | SEC ↗ |
| Nov 5, 2020 | Steven Boyd | 10% Owner | Purchase | 3.1K | $3.56 | $11.0K | SEC ↗ |
| Sep 25, 2020 | Steven Boyd | 10% Owner | Purchase | 2.0K | $4.07 | $8.1K | SEC ↗ |
| Sep 22, 2020 | Steven Boyd | 10% Owner | Purchase | 3.3K | $4.13 | $13.6K | SEC ↗ |
| Sep 17, 2020 | Thomas Stankovich | Chief Financial Officer | Purchase | 530 | $3.00 | $1.6K | SEC ↗ |
| Sep 17, 2020 | Steven Boyd | 10% Owner | Purchase | 100 | $3.75 | $375 | SEC ↗ |
| Aug 20, 2020 | Steven Boyd | 10% Owner | Purchase | 10.0K | $3.13 | $31.2K | SEC ↗ |
| Aug 20, 2020 | Thomas Stankovich | Chief Financial Officer | Purchase | 4.1K | $3.00 | $12.3K | SEC ↗ |
| Jul 21, 2020 | Steven Boyd | 10% Owner | Purchase | 4.5K | $3.00 | $13.5K | SEC ↗ |
| Jan 31, 2020 | Steven Boyd | 10% Owner | Purchase | 3.0K | $7.13 | $21.4K | SEC ↗ |
| Dec 23, 2019 | Steven Boyd | 10% Owner | Purchase | 12.0K | $5.16 | $62.2K | SEC ↗ |
| Dec 18, 2019 | Steven Boyd | 10% Owner | Purchase | 3.0K | $5.25 | $15.8K | SEC ↗ |
| Dec 11, 2019 | Steven Boyd | 10% Owner | Purchase | 2.5K | $5.20 | $13.1K | SEC ↗ |
| Nov 27, 2019 | Steven Boyd | 10% Owner | Purchase | 2.0K | $5.43 | $10.9K | SEC ↗ |
| Nov 22, 2019 | Steven Boyd | 10% Owner | Purchase | 2.8K | $5.31 | $14.9K | SEC ↗ |
| Nov 18, 2019 | Steven Boyd | 10% Owner | Purchase | 3.7K | $6.78 | $25.3K | SEC ↗ |
| Nov 13, 2019 | Steven Boyd | 10% Owner | Purchase | 400.6K | $0.05 | $20.6K | SEC ↗ |
| Sep 19, 2019 | Steven Boyd | 10% Owner | Purchase | 396.1K | $0.05 | $19.8K | SEC ↗ |
| Sep 4, 2019 | Steven Boyd | 10% Owner | Purchase | 53.9K | $0.07 | $3.8K | SEC ↗ |
| Aug 29, 2019 | Steven Boyd | 10% Owner | Purchase | 200.0K | $0.07 | $14.0K | SEC ↗ |
| Aug 9, 2019 | Steven Boyd | 10% Owner | Purchase | 350.0K | $0.07 | $25.5K | SEC ↗ |
| Jul 26, 2019 | Steven Boyd | 10% Owner | Purchase | 500.0K | $0.08 | $39.5K | SEC ↗ |
| Feb 4, 2019 | SABBY MANAGEMENT, LLC | 10% Owner | Sale | 1.2M | — | -$2.8K | SEC ↗ |
Showing the 25 most recent of 30 Form 4 filings for ReShape Lifesciences Inc..
Most active RSLS insiders
- Steven Boyd22 filings
- SABBY MANAGEMENT, LLC6 filings
- Thomas Stankovich2 filings
Ask anything about RSLS insider activity
Use Trabud's AI agent to query ReShape Lifesciences Inc.'s Form 4 history in plain English — "Show me RSLS CEO purchases this year" or compare it against any other ticker.
Open the AI agentRSLS insider trading FAQ
Are ReShape Lifesciences Inc. insiders buying or selling?
ReShape Lifesciences Inc. insiders reported no open-market purchases or sales in the last 12 months. Since January 2019, Trabud has recorded 30 Form 4 filings for RSLS: 29 buys ($495.5K) and 1 sells (-$2.8K). Over the full record that is net buying of $498.3K.
How many insiders trade RSLS stock?
3 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for ReShape Lifesciences Inc.. The most recent filing was accepted on Dec 4, 2020.
Where does Trabud get RSLS insider trading data?
All RSLS insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.